1. Home
  2. CRVS vs TRTX Comparison

CRVS vs TRTX Comparison

Compare CRVS & TRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$8.38

Market Cap

634.0M

Sector

Health Care

ML Signal

HOLD

Logo TPG RE Finance Trust Inc.

TRTX

TPG RE Finance Trust Inc.

HOLD

Current Price

$9.17

Market Cap

708.3M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRVS
TRTX
Founded
2014
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
634.0M
708.3M
IPO Year
2016
2017

Fundamental Metrics

Financial Performance
Metric
CRVS
TRTX
Price
$8.38
$9.17
Analyst Decision
Strong Buy
Buy
Analyst Count
4
3
Target Price
$13.75
$10.75
AVG Volume (30 Days)
1.1M
545.5K
Earning Date
11-04-2025
10-28-2025
Dividend Yield
N/A
10.48%
EPS Growth
N/A
N/A
EPS
N/A
0.65
Revenue
N/A
$138,590,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$8.19
P/E Ratio
N/A
$14.14
Revenue Growth
N/A
4.13
52 Week Low
$2.54
$6.47
52 Week High
$9.60
$9.85

Technical Indicators

Market Signals
Indicator
CRVS
TRTX
Relative Strength Index (RSI) 50.42 60.49
Support Level $8.31 $9.01
Resistance Level $9.60 $9.22
Average True Range (ATR) 0.54 0.14
MACD -0.09 0.01
Stochastic Oscillator 23.25 89.77

Price Performance

Historical Comparison
CRVS
TRTX

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

About TRTX TPG RE Finance Trust Inc.

TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating rate first mortgage loans that are secured by high quality commercial real estate properties undergoing some form of transition and value creation.

Share on Social Networks: